Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice
Early-stage chronic lung disease: overuse of inhaled steroids in the UK Inhaled steroids are often prescribed to early-stage chronic lung disease patients in the UK despite guidelines to the contrary. Patients newly diagnosed with early-stage chronic obstructive pulmonary disease (COPD) should not b...
Main Authors: | James D. Chalmers, Abigail Tebboth, Alicia Gayle, Andrew Ternouth, Nick Ramscar |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-06-01
|
Series: | npj Primary Care Respiratory Medicine |
Online Access: | https://doi.org/10.1038/s41533-017-0040-z |
Similar Items
-
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)
by: James D. Chalmers, et al.
Published: (2018-04-01) -
UK-specific cost-effectiveness of tiotropium + olodaterol fixed-dose combination versus other LAMA + LABA combinations in patients with COPD
by: Tebboth A, et al.
Published: (2016-11-01) -
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
by: Bloom CI, et al.
Published: (2020-04-01) -
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
by: Bloom CI, et al.
Published: (2020-04-01) -
Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms
by: Avdeev S, et al.
Published: (2019-06-01)